Refeyn is a biotechnology company that develops mass photometry instruments and software for measuring the mass and interactions of individual biomolecules, especially proteins and complexes. Its products serve academic researchers and biopharmaceutical and life-science organizations involved in protein characterization and research.
Subscribe to see Refeyn’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Refeyn is a biotech company headquartered in Oxford, United Kingdom, founded in 2018. Xcout recorded 23 job postings from Refeyn in the last 90 days.
Xcout recorded 23 job postings from Refeyn in the last 90 days, from a hiring record Xcout has kept since August 2026.
The weekly hiring trend, the roles and locations behind it — see Refeyn's hiring signals →
A few of Refeyn's closest competitors — see the full list of competitors and alternatives →
Nicoya Lifesciences Inc. is a biotechnology company headquartered in Kitchener, Ontario, Canada, that develops advanced analytical instruments and mass spectrometry platforms. The company's technologies are used by researchers worldwide to measure protein dynamics and accelerate life science discoveries.
Gator Bio is a biotechnology company that develops label-free, real-time protein quantification and characterization instruments and biosensors. Its products serve biopharmaceutical researchers and process-development teams working on antibody and other protein therapeutics.
Exciting Instruments Limited is a life sciences technology company headquartered in Sheffield, United Kingdom, that develops single-molecule detection instruments for academic and pharmaceutical laboratories. Backed by substantial funding, the company aims to make advanced molecular research more accessible and effective.
ProteinSimple, a Bio-Techne brand, provides instruments and consumables powering protein research. Its primary location and operations are based in Minneapolis, Minnesota, United States.
Nanolive SA develops automated, label-free live cell imaging platforms and AI-powered analysis software. The company serves researchers and organizations in biotechnology and pharmaceutical applications, including oncology, drug discovery, and cell metabolism.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Refeyn? Suggest a correction
Post the link and the card appears automatically — each network fetches the image itself.